Holder of Invivyd (IVVD) equity plans Rule 144 sale of 66,000 shares

Rhea-AI Filing Summary

Invivyd Inc. filed a Form 144 notice for a planned resale of 66,000 shares of its common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the Nasdaq, with an aggregate market value of $102,960.00 based on the filing.

The securities relate to common stock acquired on 02/15/2026 upon vesting of restricted stock units granted under the company’s 2021 Equity Incentive Plan as equity compensation. The company reported 281,987,033 common shares outstanding in the same class at the time referenced in the notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	66000	102960.00	281987033	02/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/15/2026	Common Stock acquired upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan	Issuer			165000	02/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Invivyd (IVVD) disclose in this Form 144 filing?

Invivyd discloses a planned sale of common stock under Rule 144. The notice covers 66,000 common shares proposed for resale through Morgan Stanley Smith Barney LLC on Nasdaq, giving investors visibility into an intended secondary sale by an existing holder.

How many Invivyd (IVVD) shares are covered by this Form 144?

The Form 144 covers 66,000 shares of Invivyd common stock. These shares are part of an intended resale by an existing holder, with an aggregate market value of $102,960.00 as stated in the filing, based on the pricing used in the notice.

What is the origin of the Invivyd (IVVD) shares being sold under Rule 144?

The shares stem from vested restricted stock units under Invivyd’s 2021 Equity Incentive Plan. The filing notes that common stock was acquired on 02/15/2026 as equity compensation when RSUs vested, and a portion of those shares is now proposed for resale.

When are the Invivyd (IVVD) shares expected to be sold according to the Form 144?

The notice lists an approximate sale date of 02/17/2026. This date reflects when the holder expects to begin selling the 66,000 Invivyd common shares under Rule 144, subject to market conditions and applicable regulatory requirements at that time.

Which broker is handling the planned Invivyd (IVVD) Form 144 sale?

Morgan Stanley Smith Barney LLC is listed as the broker. The broker’s Executive Financial Services division at One New York Plaza is named in the filing as handling the proposed resale of 66,000 Invivyd common shares on the Nasdaq exchange.

How many Invivyd (IVVD) common shares were outstanding according to the Form 144?

The filing notes 281,987,033 Invivyd common shares outstanding. This figure provides context for the scale of the 66,000-share proposed sale, indicating the overall size of the company’s common equity base in the same class of securities.